UMIN-CTR Clinical Trial

Basic information
Public title	A study on the gender preference of practitioners in abdominal ultrasonography
Acronym	A study on the gender preference of practitioners in abdominal ultrasonography
Scientific Title	A study on the gender preference of practitioners in abdominal ultrasonography
Scientific Title:Acronym	A study on the gender preference of practitioners in abdominal ultrasonography
Region	Japan

Condition
Condition	Patients scheduled for Abdominal ultrasonography at our hospital
Classification by specialty	Gastroenterology Hepato-biliary-pancreatic medicine
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	On abdominal ultrasonography, we determine the proportion of patients who want the same sex.
Basic objectives2	Others
Basic objectives -Others	We identify the factors that influence the desire for same-sex enforcers.
Trial characteristics_1	Others
Trial characteristics_2	Others
Developmental phase

Assessment
Primary outcomes	Gender preference of subject's enforcer
Key secondary outcomes	Reasons for gender preference

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	1) Patients who needed a abdominal ultrasonography screening test 2) Over 20 years old 3) After the informed consent is sufficient for participation in this study, the study subject's own approval has been obtained.
Key exclusion criteria	1) Patients who cannot communicate. 2) Patients who cannot fill out the questionnaire themselves.
Target sample size	40

Research contact person
Name of lead principal investigator	1st name Sho Middle name Last name Suzuki
Organization	Nihon University Hospital
Division name	Division of Gastroenterology and Hepatology, Department of Medicine
Zip code	101-8309
Address	1-6 Kanda Surugadai, Chiyoda-ku, Tokyo
TEL	0332931711
Email	s.sho.salubriter.mail@gmail.com

Public contact
Name of contact person	1st name Kanako Middle name Last name Ogura
Organization	Nihon University Hospital
Division name	Division of Gastroenterology and Hepatology, Department of Medicine
Zip code	101-8309
Address	1-6 Kanda Surugadai, Chiyoda-ku, Tokyo
TEL	0332931711
Homepage URL
Email	k.ogura0809@gmail.com

Sponsor
Institute	Nihon University Hospital
Institute
Department

Funding Source
Organization	None
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Nihon University Hospital Clinical Research Review Committee
Address	1-6 Kanda Surugadai, Chiyoda-ku, Tokyo
Tel	0332931711
Email	kogura0809@yahoo.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2020 Year 03 Month 16 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	No longer recruiting
Date of protocol fixation	2020 Year 02 Month 13 Day
Date of IRB	2020 Year 02 Month 13 Day
Anticipated trial start date	2020 Year 03 Month 16 Day
Last follow-up date	2020 Year 10 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	A questionnaire is distributed to the target patients, and the collected responses are analyzed using a chi-square test.

Management information
Registered date	2020 Year 03 Month 14 Day
Last modified on	2020 Year 05 Month 19 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045406